Genzyme Asks For Campath Label Expansion To First-Line Lymphocytic Leukemia
This article was originally published in The Pink Sheet Daily
Executive Summary
Data supporting the B-cell lymphocytic leukemia sBLA also completes Campath’s 2001 Phase IV obligation.